NEW YORK (GenomeWeb) – Pharmacogenomic testing firm AltheaDx today announced it has raised $30 million in Series C financing.

WuXi Healthcare Ventures led the round, joined by WuXi PharmaTech, Ally Bridge Group, and Alma Life Sciences.

AltheaDx said it would use the funds for prospective trials for its IDgenetix test portfolio, product enhancements, and other growth opportunities.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.